+

WO2017167849A1 - Composition enzymatique et préparation d'un produit laitier aux propriétés améliorées - Google Patents

Composition enzymatique et préparation d'un produit laitier aux propriétés améliorées Download PDF

Info

Publication number
WO2017167849A1
WO2017167849A1 PCT/EP2017/057490 EP2017057490W WO2017167849A1 WO 2017167849 A1 WO2017167849 A1 WO 2017167849A1 EP 2017057490 W EP2017057490 W EP 2017057490W WO 2017167849 A1 WO2017167849 A1 WO 2017167849A1
Authority
WO
WIPO (PCT)
Prior art keywords
activity
seq
lactase
sequence
enzyme composition
Prior art date
Application number
PCT/EP2017/057490
Other languages
English (en)
Inventor
Petrus Jacobus Theodorus Dekker
Cornelis Marinus Muijlwijk
Marten Aalt PAASMAN
Original Assignee
Dsm Ip Assets B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets B.V. filed Critical Dsm Ip Assets B.V.
Priority to EP17714719.6A priority Critical patent/EP3435772A1/fr
Publication of WO2017167849A1 publication Critical patent/WO2017167849A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G9/00—Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor
    • A23G9/32—Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor characterised by the composition containing organic or inorganic compounds
    • A23G9/36—Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/1203—Addition of, or treatment with, enzymes or microorganisms other than lactobacteriaceae
    • A23C9/1206—Lactose hydrolysing enzymes, e.g. lactase, beta-galactosidase
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/137—Thickening substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G9/00—Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor
    • A23G9/32—Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor characterised by the composition containing organic or inorganic compounds
    • A23G9/40—Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor characterised by the composition containing organic or inorganic compounds characterised by the dairy products used
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01108—Lactase (3.2.1.108)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C2260/00—Particular aspects or types of dairy products
    • A23C2260/15—Frozen dairy products

Definitions

  • the present invention relates to a dairy product obtainable by a process in which a milk-based substrate comprising lactose is treated with an enzyme composition comprising lactase activity.
  • the invention also relates to the dairy product itself, to use an enzyme composition comprising lactase activity in the production of a dairy product and to the enzyme composition itself.
  • Lactose intolerance is perhaps the best-known food sensitivity in the United States and other parts of the world. It is estimated that about 70% of the world's population has a genetically controlled limited ability to digest lactose. Accordingly, there is a growing demand for dairy food products that contain no or only low levels of lactose.
  • Lactase is used commercially to break down lactose in milk to produce dairy products which are suitable for people with lactose intolerance and/or have a sweeter taste. Because glucose and galactose are sweeter than lactose, lactase produces a more pleasant taste. Lactase is also used in the manufacture of ice cream. Lactose crystallizes at the low temperatures of ice cream, whereas glucose and galactose stay liquid and contribute to a smoother texture. Lactase is also used in the conversion of whey into syrup and for the production of condensed milk.
  • high temperatures are used. These high temperatures may lead to higher activity of contaminating side activities present in a lactase composition such that additional low temperature steps need to be incorporated into the process for making the dairy product.
  • the use of a lactase composition which has reduced arylsulfatase activity, invertase activity, lipase activity and/or amylase activity means that such a composition can be used at higher temperatures without the side activities destabilising (processing of) the dairy product.
  • the invention relates to a dairy product obtainable by a process which comprises:
  • lactase activity is provided by a polypeptide having an amino acid sequence which comprises the sequence set out in SEQ ID NO: 1 or SEQ ID NO: 2, a truncated version of either thereof or a sequence having at least about 60% sequence identity to any thereto, and
  • the enzyme composition has reduced arylsulfatase activity, invertase activity, lipase activity and/or amylase activity.
  • the invention relates to a dairy product obtainable by a process which comprises:
  • lactase activity is provided by a polypeptide having an amino acid sequence which comprises the sequence set out in SEQ ID NO: 1 or SEQ ID NO: 2 or SEQ ID NO: 3 or SEQ ID NO: 4 or a sequence having at least about 60% sequence identity to any thereto, and
  • the enzyme composition has reduced arylsulfatase activity, invertase activity, lipase activity and/or amylase activity.
  • the invention also relates to a dairy product obtainable by a process which comprises:
  • the enzyme composition has reduced arylsulfatase activity, invertase activity, lipase activity and/or amylase activity.
  • the invention also provides:
  • a method for the production of a dairy product which method comprises:
  • lactase activity is provided by a polypeptide having an amino acid sequence which comprises the sequence set out in SEQ ID NO: 1 or SEQ ID NO: 2, a truncated version of either thereof or a sequence having at least about 60% sequence identity to any thereto, and
  • the enzyme composition has reduced arylsulfatase activity, invertase activity, lipase activity and/or amylase activity;
  • a method for the production of a dairy product which method comprises:
  • lactase activity is provided by a polypeptide having an amino acid sequence which comprises the sequence set out in SEQ ID NO: 1 or SEQ ID NO: 2 or SEQ ID NO: 3 or SEQ ID NO: 4 or a sequence having at least about 60% sequence identity to any thereto, and
  • the enzyme composition has reduced arylsulfatase activity, invertase activity, lipase activity and/or amylase activity;
  • a method for the production of a dairy product which method comprises:
  • lactase activity is provided by a polypeptide having lactase activity which is derived from Bifidobacterium bifidum, and
  • the enzyme composition has reduced arylsulfatase activity, invertase activity, lipase activity and/or amylase activity; use of an enzyme having lactase activity in the production of a dairy product with improved taste and/or shelf-lie, wherein dairy product obtainable by a process which comprises:
  • lactase activity is provided by a polypeptide having an amino acid sequence which comprises the sequence set out in SEQ ID NO: 1 or SEQ ID NO: 2, a truncated version of either thereof or a sequence having at least about 60% sequence identity to any thereto, and
  • the enzyme composition has reduced arylsulfatase activity, invertase activity, lipase activity and/or amylase activity;
  • dairy product obtainable by a process which comprises:
  • lactase activity is provided by a polypeptide having an amino acid sequence which comprises the sequence set out in SEQ ID NO: 1 or SEQ ID NO: 2 or SEQ ID NO: 3 or SEQ ID NO: 4 or a sequence having at least about 60% sequence identity to any thereto, and
  • the enzyme composition has reduced arylsulfatase activity, invertase activity, lipase activity and/or amylase activity;
  • dairy product obtainable by a process which comprises:
  • lactase activity is provided by a polypeptide having lactase activity which is derived from Bifidobacterium bifidum, and wherein the enzyme composition has reduced arylsulfatase activity, invertase activity, lipase activity and/or amylase activity;
  • an enzyme composition comprising lactase activity, wherein at least a part of the lactase activity is provided by a polypeptide having an amino acid sequence which comprises the sequence set out in SEQ I D NO: 1 or SEQ ID NO: 2, a truncated version of either thereof or a sequence having at least about 60% sequence identity to any thereto, which has reduced arylsulfatase activity, invertase activity, lipase activity and/or amylase activity;
  • an enzyme composition comprising lactase activity, wherein at least a part of the lactase activity is provided by a polypeptide having an amino acid sequence which comprises the sequence set out in SEQ ID NO: 1 or SEQ ID NO: 2 or SEQ ID NO: 3 or SEQ ID NO: 4 or a sequence having at least about 60% sequence identity to any thereto, which has reduced arylsulfatase activity, invertase activity, lipase activity and/or amylase activity; and
  • an enzyme composition comprising lactase activity, wherein at least a part of the lactase activity is provided by a polypeptide having lactase activity which is derived from Bifidobacterium bifidum which has reduced arylsulfatase activity, invertase activity, lipase activity and/or amylase activity.
  • SEQ ID NOs: 1 and 2 set out the polypeptide sequences of lactase enzymes from Bifidobacterium bifidum.
  • SEQ ID NO: 1 may also be defined with reference to SEQ ID NO: 2 in WO01/90317.
  • SEQ ID NO: 2 may also be defined with reference to the Bbg3 sequence described in Goulas T.K., Goulas A.K., Tzortzis G., Gibson G.R., Appl. Microbiol. Biotechnol. 76(6), 1365 and 1372 (2007).
  • SEQ ID NO: 3 a C-terminal truncation variant, may also be defined with reference to SEQ ID NO: 2 as described in WO2009/071539.
  • SEQ ID NO: 4 another C-terminal truncation variant, may also be defined with reference to SEQ ID NO: 2 as described in WO2014/184189.
  • the treatment of the substrate may involve any process wherein a substrate is contacted with the enzyme preparation.
  • the treatment may involve any process wherein the substrate is incubated in the presence of the enzyme preparation.
  • a high temperature process herein may be a process which is carried out at at least about 45°C, for example at at least about 45°C or at a higher temperature such as at least 50°C, at least 55°C, at least 60°C or at least above 60°C such as at least 61 , 62, 63, 64 or 65°C.
  • the enzyme preparation may be added to the substrate in any suitable manner.
  • the process may be any process wherein a product is produced, for instance a nutritive product, preferably a dairy product.
  • Milk-based substrate in this invention may be any raw and/or processed milk material.
  • Useful milk-based substrates include, but are not limited to solutions/suspensions of any milk or milk like products comprising lactose, such as whole milk, low fat milk, skim milk, buttermilk, reconstituted milk from milk powder, condensed milk, solutions of dried milk, UHT milk or cream.
  • a dairy product encompasses any composition that contains milk protein, for instance casein and/or whey protein.
  • milk protein for instance casein and/or whey protein.
  • milk-derived products e.g. yoghurt, for example stirred, set or greek
  • condensed milk e.g. yoghurt, for example stirred, set or greek
  • condensed milk e.g. yoghurt, for example stirred, set or greek
  • condensed milk e.g. yoghurt, for example stirred, set or greek
  • condensed milk evaporated milk
  • dry milk frozen milk
  • ice cream ice cream
  • whey e.g. whey
  • cheese for example fresh or hard cheese.
  • the dairy product may also be a milk powder and/or a hydrolysate.
  • a dairy product may be plain or flavoured.
  • dairy products which are to be made using high temperature conditions, for example a starch containing product such as a custard.
  • Yet another preferred dairy product is ice cream.
  • Preferred dairy products are custard and ice cream.
  • the milk protein may be derived from a mammal or a plant sources or mixtures thereof.
  • the milk protein is from a mammal source.
  • Mammals sources of milk protein include, but are not limited to cow, sheep, goat, buffalo, camel, llama, mare and deer.
  • the milk protein is from a mammal selected from the group consisting of cow, sheep, goat, buffalo, camel, llama, mare and deer, and combinations thereof.
  • Plant sources of milk protein include, but are not limited to, milk extracted from soy bean, pea, peanut, barley, rice, oat, quinoa, almond, cashew, coconut, hazelnut, hemp, sesame seed and sunflower seed. Soy bean milk protein is preferred.
  • milk refers to not only whole milk, but also skim milk or any liquid component derived thereof.
  • the invention also relates to the use of the enzyme preparation according to the invention to improve processability, especially in higher temperature process and/or prevent or reduce the development of off-flavor and/or to improve texture.
  • an enzyme preparation has a reduced activity of a given enzyme if the activity of the given enzyme in the preparation has been reduced as compared with an identical preparation in which no steps are taken to reduce activity of the enzyme.
  • an enzyme preparation having lactase activity and having reduced activity of a given enzyme such as arylsulfatase activity, invertase activity, lipase activity and/or amylase activity
  • a given enzyme such as arylsulfatase activity, invertase activity, lipase activity and/or amylase activity
  • An enzyme preparation with reduced arylsulfatase activity, invertase activity, lipase activity and/or amylase activity may also thus encompass an enzyme preparation obtained by purifying a crude enzyme preparation which lactase activity, wherein at least some of the arylsulfatase activity, invertase activity, lipase activity and/or amylase activity is separated from the lactase.
  • a host microorganism used to express a lactase may be modified so that the activity of one or more given enzymes, such as arylsulfatase, invertase, lipase and/or amylase (expressed by the host), is reduced partly or completely, for example by modification or part or complete deletion of a nucleic acid sequence encoding an arylsulfatase, invertase, lipase and/or amylase or by modification or part or complete deletion of a nucleic acid sequence encoding a polypeptide involved in the regulation of an arylsulfatase, invertase, lipase and/or amylase.
  • arylsulfatase invertase, lipase and/or amylase
  • a genetic approach may be used to produce an enzyme composition comprising lactase activity having reduced activity of a given enzyme, such as arylsulfatase activity, invertase activity, lipase activity and/or amylase activity.
  • the invention provides a process in which a modified host is used to express a lactase having reduced arylsulfatase activity, invertase activity, lipase activity and/or amylase activity and then that lactase composition is used as described herein.
  • the enzyme composition is reduced in/substantially free from arylsulfatase activity.
  • the enzyme composition is reduced in/substantially free from lipase activity.
  • the enzyme composition is reduced in/substantially free from lipase activity.
  • the enzyme composition is reduced in/substantially free from amylase activity.
  • Combinations are reduced activity/substantially free from: arylsulfatase and invertase activity; arylsulfatase and lipase activity; arylsulfatase and amylase activity; invertase and lipase activity; invertase and amylase activity; lipase and amylase activity; arylsulfatase, invertase and lipase activity; arylsulfatase, invertase and amylase activity; invertase, lipase and amylase activity or arylsulfatase, invertase, lipase and amylase activity. Any such combination may be combined with a reduction in protease activity.
  • composition of the invention may have reduced activity of or may be substantially free of two or three such activities.
  • the activity of a given enzyme such as arylsulfatase activity, invertase activity, lipase activity and/or amylase activity, in an enzyme composition comprising lactase activity may be reduced by at least about 10%, at least about 20%, at least about 30%, at least about 40%, at least about 50%, at least about 60%, at least about 70%, at least about 80%, at least about 90%, at least about 95% or more.
  • the percentage decrease represents the reduction as compared with an identical composition where no steps are taken to reduce arylsulfatase activity, invertase activity, lipase activity and/or amylase activity.
  • one or more genetic modifications may be made to reduce arylsulfatase activity, invertase activity, lipase activity and/or amylase activity by the desired amount (as compared to a non-modified host).
  • An enzyme composition of the invention may be substantially free from arylsulfatase activity, invertase activity, lipase activity and/or amylase activity. This typically implies a reduction in activity of at least about 50%, but more typically of at least about 80% or higher, such as a reduction of at least about 95% or a greater reduction.
  • a purification step that has the effect that the activity of protease relative to the activity of lactase is reduced may be used.
  • the purifying results in a reduction of arylsulfatase activity, invertase activity, lipase activity and/or amylase activity of at least 50%, preferably at least 80%, more preferably at least 90%, more preferably at least 95%, more preferably at least 99%.
  • ur arylsulfatase activity, invertase activity, lipase activity and/or amylase activity in purified enzyme preparation (unit/ml)
  • ur activity of lactase in purified enzyme preparation (unit/ml)
  • aenzyme arylsulfatase activity, invertase activity, lipase activity and/or amylase activity in crude enzyme preparation (unit/ml)
  • aiactase.cmde activity of lactase in crude enzyme preparation (unit/ml)
  • the purification can be effected in any suitable manner.
  • the purifying is by chromatography.
  • Processes for purifying enzyme preparations using chromatography are known per se. Selecting the most appropriate chromatographic separation methods depend on molecular characteristics of both the relevant enzyme and of the relevant arylsulfatase activity present. Relevant molecular characteristics are the isoelectric point, hydrophobicity, molecular surface charge distribution, molecular weight of the relevant enzyme and the side activity as well as several other protein chemical properties. A practical background on the use of these characteristics in selecting the appropriate chromatographic separation process, can be found in a.o. the Protein Purification Handbook (issued by Amersham Pharmacia Biotech, nowadays GE Healthcare Bio-Sciences, Diegem, Belgium). Suitable chromatographic separation methods comprise ion exchange chromatography, affinity chromatography, size exclusion chromatography, hydrophobic interaction chromatography and others. For the present invention ion exchange chromatography or hydrophobic interaction chromatography are preferred.
  • An enzyme preparation of the invention may encompass an enzyme preparation wherein the ratio of the arylsulfatase activity, invertase activity, lipase activity and/or amylase activity divided by the activity of the lactase is below a specified value.
  • Preferred ratio's may vary depending on the enzyme and application used.
  • arylsulfatase activity is meant the sulphuric ester hydrolase activity able to cleave a phenol sulfate into the phenol and sulfate moiety as described for EC 3.1 .6.1 .
  • invertase activity is meant the activity that catalyzes the hydrolysis (breakdown) of sucrose as described in EC 3.2.1 .26.
  • lipase activity is meant the activity that catalyzes the hydrolysis of lipids.
  • amylase activity is meant the activity that catalyzes the hydrolysis of starch into sugars.
  • protease activity is meant the activity that catalyzes the hydrolysis of proteins.
  • An enzyme composition of the invention having lactase activity and having reduced arylsulfatase activity, invertase activity, lipase activity and/or amylase activity may also have one or more of reduced protease activity.
  • An enzyme composition of the invention may have reduced activity of all of these enzyme activities.
  • An enzyme composition of the invention may be substantially free from all of these enzyme activities. Additionally, the enzyme preparation may also be free from protease.
  • At least a part of the lactase activity in the enzyme composition may be provided by a polypeptide having an amino acid sequence which comprises the sequence set out in SEQ ID NO: 1 or SEQ ID NO: 2, a truncated version of either thereof or a sequence having at least about 60% sequence identity to any thereto.
  • Reference to a truncated version refers to a C-terminal truncated version.
  • At least a part of the lactase activity in the enzyme composition may be provided by a polypeptide having an amino acid sequence which comprises the sequence set out in SEQ ID NO: 1 or SEQ ID NO: 2 or SEQ ID NO: 3 or SEQ I D NO: 4 or a sequence having at least about 60% sequence identity to any thereto.
  • at least a part of the lactase activity is provided by a polypeptide having lactase activity which is derived from Bifidobacterium bifidum.
  • a substance e.g., a nucleic acid molecule or polypeptide
  • derived from a microorganism preferably means that the substance is native to that microorganism or is a variant based on a substance native to the microorganism (for example a truncated version of a polypeptide derived from the microorganism and/or a version which contains one or more substitutions as compared to a polypeptide derived from the microorganism).
  • polypeptide set out in SEQ ID NO: 1 or SEQ ID NO: 2 of the invention is the full-length wild-type sequence of a lactase from Bifidobacterium bifidum.
  • a polypeptide having lactase activity suitable for use in the invention may have comprise an amino acid sequence having at least about 60%, at least about 70%, at least about 75%, at least about 80%, at least about 85%, at least about, 86%, at least about 87%, at least about 88%, at least about 89%, at least about 90%, at least about 91 %, at least about 92%, at least about 93%, at least about 94%, at least about 95%, at least about 96%, at least about 97%, at least about 98% or at least about 99% sequence identity to SEQ ID NO: 1 or SEQ ID NO: 2.
  • SEQ ID NO: 1 and 2 both comprise a signal sequence which is positioned at amino acids 1 to 32 for both of them.
  • a polypeptide having lactase activity for use in the invention preferably comprises:
  • amino acid sequence having at least about 60%, at least about 70%, at least about 75%, at least about 80%, at least about 85%, at least about, 86%, at least about 87%, at least about 88%, at least about 89%, at least about 90%, at least about 91 %, at least about 92%, at least about 93%, at least about 94%, at least about 95%, at least about 96%, at least about 97%, at least about 98% or at least about 99% sequence identity to amino acids 33 to 1752 of SEQ ID NO: 1 .
  • amino acid sequence having at least about 60%, at least about 70%, at least about 75%, at least about 80%, at least about 85%, at least about, 86%, at least about 87%, at least about 88%, at least about 89%, at least about 90%, at least about 91 %, at least about 92%, at least about 93%, at least about 94%, at least about 95%, at least about 96%, at least about 97%, at least about 98% or at least about 99% sequence identity to amino acids 33 to 1935 of SEQ ID NO: 2.
  • a truncated version of the polypeptide of SEQ ID NO: 1 or SEQ ID NO: 2, or more preferably a truncated version of amino acids 33 to 1752 of SEQ ID NO: 1 or a truncated version of amino acids 33 to 1935 of SEQ ID NO:2, may be used or a polypeptide comprising an amino acid sequence having at least about 60%, at least about 70%, at least about 75%, at least about 80%, at least about 85%, at least about, 86%, at least about 87%, at least about 88%, at least about 89%, at least about 90%, at least about 91 %, at least about 92%, at least about 93%, at least about 94%, at least about 95%, at least about 96%, at least about 97%, at least about 98% or at least about 99% sequence identity to such a truncated version of SEQ ID NO: 1 OR SEQ ID NO: 2 or more preferred to a truncated version of amino acids 33 to 1752 of SEQ ID NO:
  • polypeptide having lactase activity suitable for use in the invention is the Bbg3 polypeptide described in Goulas T.K., Goulas A.K., Tzortzis G., Gibson G.R., Appl. Microbiol. Biotechnol. 76(6), 1365 and 1372 (2007).
  • Suitable truncated versions of the polypeptide of SEQ ID NO: 1 or SEQ ID NO: 2 include SEQ ID NO: 2 in WO2009/071539 (herein SEQ ID NO: 3) and SEQ ID NOs: 1 or 2 in WO2014/184189 (SEQ ID NO: 2 of WO2014/184189 is SEQ ID NO: 4 in this patent application).
  • the invention provides a dairy product or a method according to the invention in which SEQ ID NO: 3 or 4 is used or a polypeptide comprising an amino acid sequence having at least about 60%, at least about 70%, at least about 75%, at least about 80%, at least about 85%, at least about, 86%, at least about 87%, at least about 88%, at least about 89%, at least about 90%, at least about 91 %, at least about 92%, at least about 93%, at least about 94%, at least about 95%, at least about 96%, at least about 97%, at least about 98% or at least about 99% sequence identity to SEQ ID NO: 3 or SEQ ID NO: 4.
  • SEQ ID NO: 3 and 4 both comprise a signal sequence which is positioned at amino acids 1 to 27 for both of them.
  • a polypeptide having lactase activity for use in the invention preferably comprises:
  • amino acid sequence having at least about 60%, at least about 70%, at least about 75%, at least about 80%, at least about 85%, at least about, 86%, at least about 87%, at least about 88%, at least about 89%, at least about 90%, at least about 91 %, at least about 92%, at least about 93%, at least about 94%, at least about 95%, at least about 96%, at least about 97%, at least about 98% or at least about 99% sequence identity to amino acids 28 to 1341 of SEQ I D NO: 3, more preferably amino acids 28-1331 of SEQ ID NO: 3 (as amino acids 1332-1341 comprise a purification tag which is preferably removed)
  • amino acid sequence having at least about 60%, at least about 70%, at least about 75%, at least about 80%, at least about 85%, at least about, 86%, at least about 87%, at least about 88%, at least about 89%, at least about 90%, at least about 91 %, at least about 92%, at least about 93%, at least about 94%, at least about 95%, at least about 96%, at least about 97%, at least about 98% or at least about 99% sequence identity to amino acids 28 to 1331 of SEQ ID NO: 4.
  • the invention concerns a dairy product obtainable by a process which comprises:
  • lactase activity is provided by a polypeptide having an amino acid sequence which comprises the sequence set out in SEQ ID NO: 1 , 2, 3 or 4 or a sequence having at least 60% sequence identity to SEQ ID NO: 1 , 2, 3 or 4 wherein the enzyme composition has reduced arylsulfatase activity, invertase activity, lipase activity and/or amylase activity.
  • At least part of the lactase activity is provided by a polypeptide having an amino acid sequence which comprises the sequence set out in amino acids 33 to 1752 of SEQ ID NO: 1 , amino acids 33 to 1935 of SEQ I D NO: 2, amino acids 28 to 1331 of SEQ ID NO:3 or amino acids 28 to 1331 of SEQ ID NO: 4 or a sequence having at least 60% sequence identity to any thereto.
  • the invention also concerns a method for the production of a dairy product, which method comprises:
  • lactase activity is provided by a polypeptide having an amino acid sequence which comprises the sequence set out in SEQ ID NO: 1 , 2, 3 or 4 or a sequence having at least 60% sequence identity to SEQ ID NO: 1 , 2, 3 or 4 wherein the enzyme composition has reduced arylsulfatase activity, invertase activity, lipase activity and/or amylase activity.
  • At least part of the lactase activity is provided by a polypeptide having an amino acid sequence which comprises the sequence set out in amino acids 33 to 1752 of SEQ ID NO: 1 , amino acids 33 to 1935 of SEQ I D NO: 2, amino acids 28 to 1331 of SEQ ID NO:3 or amino acids 28 to 1331 of SEQ ID NO: 4 or a sequence having at least 60% sequence identity to any thereto.
  • sequence homology or “sequence identity” or “homology” or “identity” are used interchangeably herein.
  • sequences are aligned for optimal comparison purposes.
  • gaps may be introduced in any of the two sequences that are compared.
  • alignment can be carried out over the full length of the sequences being compared.
  • the alignment may be carried out over a shorter length, for example over about 20, about 50, about 100 or more nucleic acids/based or amino acids.
  • sequence identity is the percentage of identical matches between the two sequences over the reported aligned region.
  • a comparison of sequences and determination of percentage of sequence identity between two sequences can be accomplished using a mathematical algorithm.
  • the skilled person will be aware of the fact that several different computer programs are available to align two sequences and determine the identity between two sequences (Kruskal, J. B. (1983) An overview of sequence comparison In D. Sankoff and J. B. Kruskal, (ed.), Time warps, string edits and macromolecules: the theory and practice of sequence comparison, pp. 1 -44 Addison Wesley).
  • the percent sequence identity between two amino acid sequences or between two nucleotide sequences may be determined using the Needleman and Wunsch algorithm for the alignment of two sequences. (Needleman, S. B. and Wunsch, C. D. (1970) J. Mol. Biol.
  • the percentage of sequence identity between a query sequence and a sequence of the invention is calculated as follows: Number of corresponding positions in the alignment showing an identical amino acid or identical nucleotide in both sequences divided by the total length of the alignment after subtraction of the total number of gaps in the alignment.
  • the identity defined as herein can be obtained from NEEDLE by using the NOBRIEF option and is labeled in the output of the program as "longest-identity".
  • nucleic acid and protein sequences of the present invention can further be used as a "query sequence" to perform a search against public databases to, for example, identify other family members or related sequences.
  • search can be performed using the NBLAST and XBLAST programs (version 2.0) of Altschul, et al. (1990) J. Mol. Biol. 215:403—10.
  • Gapped BLAST can be utilized as described in Altschul et al., (1997) Nucleic Acids Res. 25(17): 3389-3402.
  • the default parameters of the respective programs e.g., XBLAST and NBLAST
  • Example 1 Preparation of a lactase composition comprising substantially no arylsulfatase activity, invertase activity, lipase activity and/or amylase activity and its use in the preparation of an ice-cream
  • a lactase composition is prepared by expressing lactases in Bacillus subtilis.
  • Lad 6 is described in WO2009/071538 (SEQ ID NO: 2; herein SEQ ID NO: 3) and lad 9 (herein SEQ ID NO: 2) is described as Bbg3 in Goulas T.K., Goulas A.K., Tzortzis G., Gibson G.R., Appl. Microbiol. Biotechnol. 76(6), 1365 and 1372 (2007).
  • a lactase having SEQ ID NO: 3 or 4, or more preferably amino acids 28- 1331 of SEQ ID NO: 3 or 4, is used.
  • Standard genetic techniques such as overexpression of enzymes in the host cells, genetic modification of host cells, or hybridisation techniques, are known methods in the art, such as described in Sambrook and Russel (2001 ) "Molecular Cloning: A Laboratory Manual (3 rd edition), Cold Spring Harbor Laboratory, Cold Spring Harbor Laboratory Press, or F. Ausubel et al, eds., "Current protocols in molecular biology", Green Publishing and Wiley Interscience, New York (1987). Methods for transformation, genetic modification etc of fungal host cells are known from e.g.
  • Enzymes were isolated from the fermentation broth of Bacillus subtilis strains and purified using standard centrifugation and filtration techniques.
  • compositions are prepared so that they comprise substantially no arylsulfatase activity, invertase activity, lipase activity and/or amylase activity. This can be carried out using a biochemical method to reduce the amount of protease in the composition. Alternatively, it can be carried out by modifying the host organism in which the lactase is prepared such that the amount of protease produced by the host organism is reduced.
  • compositions are then used in the manufacture of an ice-cream. This comprises the steps of:
  • the raw materials can be split into 2 groups liquid and dry raw materials.
  • the liquid raw materials are usually: condensed milk; cream; corn sugar; cane sugar and water.
  • the dry ingredients are usually flavors; fruit; nuts; stabilizers; milk powder; whey powder; emulsifiers; egg-powder; and sugar.
  • the dry ingredients are blended with the liquid ingredients prior to pasteurization of the total ice-cream mix together with the enzyme composition comprising lactase.
  • the dry ingredients are given enough time to completely hydrate in order to prevent lumps formation and ensure proper solubilization at the moment of pasteurization.
  • the lactase composition may be added with the wet ingredients.
  • the temperature of hydration of the dry ingredients is typically above 60°C and no hydrolysis of lactose-containing ingredients is carried out prior to blending with the other ice-cream mix ingredients.
  • the ice-cream is evaluated by a sensory panel for taste and texture characteristics.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Dairy Products (AREA)

Abstract

La présente invention concerne un produit laitier pouvant être obtenu par un procédé qui comprend : a) la fourniture d'un substrat à base de lait comprenant du lactose ; et b) le traitement dudit substrat avec une composition enzymatique comprenant une activité de la lactase, au moins une partie de l'activité de la lactase étant fournie par un polypeptide ayant une séquence d'acides aminés qui comprend la séquence définie dans SEQ ID NO: 1 ou SEQ ID NO : 2, une version tronquée de l'une ou l'autre desdites séquences ou une séquence ayant au moins environ 60 % d'identité de séquence avec l'une quelconque desdites séquences, et la composition enzymatique ayant une activité de l'arylsulfatase réduite, une activité de l'invertase, une activité de la lipase et/ou une activité de l'amylase.
PCT/EP2017/057490 2016-03-31 2017-03-30 Composition enzymatique et préparation d'un produit laitier aux propriétés améliorées WO2017167849A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP17714719.6A EP3435772A1 (fr) 2016-03-31 2017-03-30 Composition enzymatique et préparation d'un produit laitier aux propriétés améliorées

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662316389P 2016-03-31 2016-03-31
US62/316389 2016-03-31

Publications (1)

Publication Number Publication Date
WO2017167849A1 true WO2017167849A1 (fr) 2017-10-05

Family

ID=58461319

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2017/057490 WO2017167849A1 (fr) 2016-03-31 2017-03-30 Composition enzymatique et préparation d'un produit laitier aux propriétés améliorées

Country Status (2)

Country Link
EP (1) EP3435772A1 (fr)
WO (1) WO2017167849A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020127511A1 (fr) 2018-12-19 2020-06-25 Firmenich Sa Compositions laitières édulcorées comprenant des produits d'hydrolyse du lactose et des glycosides de stéviol naturels glucosylés
WO2022268875A1 (fr) 2021-06-23 2022-12-29 Firmenich Sa Compositions modifiant l'arôme contenant de la lactase

Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990014423A1 (fr) 1989-05-18 1990-11-29 The Infergene Company Transformation de microorganismes
EP0481008A1 (fr) 1989-07-07 1992-04-22 Unilever Plc Procede de preparation d'une proteine a partir d'un champignon transforme par integration multicopie d'un vecteur d'expression
EP0635574A1 (fr) 1993-07-23 1995-01-25 Gist-Brocades N.V. Souches récombinantes dépourvues de marqueurs de sélection: procédé pour leur obtention et utilisation de ces souches
WO1998046772A2 (fr) 1997-04-11 1998-10-22 Dsm N.V. Transformation genetique comme outil pour la construction de champignons filamenteux industriels de recombinaison
WO1999060102A2 (fr) 1998-05-19 1999-11-25 Dsm N.V. Perfectionnement d'un procede de production de cephalosporines
WO2000037671A2 (fr) 1998-12-22 2000-06-29 Dsm N.V. Production in vivo amelioree de cephalosporines
US6265186B1 (en) 1997-04-11 2001-07-24 Dsm N.V. Yeast cells comprising at least two copies of a desired gene integrated into the chromosomal genome at more than one non-ribosomal RNA encoding domain, particularly with Kluyveromyces
WO2001090317A2 (fr) 2000-05-26 2001-11-29 Arla Foods Amba Nouvelle enzyme isolee a partie de bifidobacterium
WO2009071538A2 (fr) 2007-12-04 2009-06-11 Shell Internationale Research Maatschappij B.V. Procédé et appareil permettant de refroidir et/ou de liquéfier un flux d'hydrocarbure
WO2009071539A1 (fr) 2007-12-03 2009-06-11 Novozymes A/S Procédé de fabrication d'un produit laitier
AU2013200779A1 (en) * 2005-11-28 2013-02-28 Dsm Ip Assets B.V. Enzyme preparations yielding a clean taste
WO2013182686A1 (fr) * 2012-06-08 2013-12-12 Dupont Nutrition Biosciences Aps Polypeptides présentant une activité de transgalactosylation
WO2014184189A2 (fr) 2013-05-14 2014-11-20 Novozymes A/S Procédé de saccharification et de fermentation simultanées de perméat de lactosérum
WO2015132349A1 (fr) * 2014-03-05 2015-09-11 Dsm Ip Assets B.V. Compositions de lactase liquides

Patent Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990014423A1 (fr) 1989-05-18 1990-11-29 The Infergene Company Transformation de microorganismes
EP0481008A1 (fr) 1989-07-07 1992-04-22 Unilever Plc Procede de preparation d'une proteine a partir d'un champignon transforme par integration multicopie d'un vecteur d'expression
EP0635574A1 (fr) 1993-07-23 1995-01-25 Gist-Brocades N.V. Souches récombinantes dépourvues de marqueurs de sélection: procédé pour leur obtention et utilisation de ces souches
US6265186B1 (en) 1997-04-11 2001-07-24 Dsm N.V. Yeast cells comprising at least two copies of a desired gene integrated into the chromosomal genome at more than one non-ribosomal RNA encoding domain, particularly with Kluyveromyces
WO1998046772A2 (fr) 1997-04-11 1998-10-22 Dsm N.V. Transformation genetique comme outil pour la construction de champignons filamenteux industriels de recombinaison
WO1999060102A2 (fr) 1998-05-19 1999-11-25 Dsm N.V. Perfectionnement d'un procede de production de cephalosporines
WO2000037671A2 (fr) 1998-12-22 2000-06-29 Dsm N.V. Production in vivo amelioree de cephalosporines
WO2001090317A2 (fr) 2000-05-26 2001-11-29 Arla Foods Amba Nouvelle enzyme isolee a partie de bifidobacterium
AU2013200779A1 (en) * 2005-11-28 2013-02-28 Dsm Ip Assets B.V. Enzyme preparations yielding a clean taste
WO2009071539A1 (fr) 2007-12-03 2009-06-11 Novozymes A/S Procédé de fabrication d'un produit laitier
WO2009071538A2 (fr) 2007-12-04 2009-06-11 Shell Internationale Research Maatschappij B.V. Procédé et appareil permettant de refroidir et/ou de liquéfier un flux d'hydrocarbure
WO2013182686A1 (fr) * 2012-06-08 2013-12-12 Dupont Nutrition Biosciences Aps Polypeptides présentant une activité de transgalactosylation
WO2014184189A2 (fr) 2013-05-14 2014-11-20 Novozymes A/S Procédé de saccharification et de fermentation simultanées de perméat de lactosérum
WO2015132349A1 (fr) * 2014-03-05 2015-09-11 Dsm Ip Assets B.V. Compositions de lactase liquides

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
"Current protocols in molecular biology", 1987, GREEN PUBLISHING AND WILEY INTERSCIENCE
ALTSCHUL ET AL., NUCLEIC ACIDS RES., vol. 25, no. 17, 1997, pages 3389 - 3402
GOULAS T.K.; GOULAS A.K.; TZORTZIS G.; GIBSON G.R., APPL. MICROBIOL. BIOTECHNOL., no. 6, 2007, pages 1365 - 1372
GOULAS T.K.; GOULAS A.K.; TZORTZIS G.; GIBSON G.R., APPL. MICROBIOL. BIOTECHNOL., vol. 76, no. 6, 2007, pages 1365 - 1372
J. MOL. BIOL., vol. 215, 1990, pages 403 - 10
KRUSKAL, J. B.: "Time warps, string edits and macromolecules: the theory and practice of sequence comparison", 1983, ADDISON WESLEY, article "An overview of sequence comparison", pages: 1 - 44
NEEDLEMAN, S. B.; WUNSCH, C. D., J. MOL. BIOL., vol. 48, 1970, pages 443 - 453
RICE,P.; LONGDEN,L; BLEASBY,A: "EMBOSS: The European Molecular Biology Open Software Suite", TRENDS IN GENETICS, vol. 16, no. 6, 2000, pages 276 - 277, XP004200114, Retrieved from the Internet <URL:http://emboss.bioinformatics.nl> DOI: doi:10.1016/S0168-9525(00)02024-2
SAMBROOK; RUSSEL: "Molecular Cloning: A Laboratory Manual", 2001, COLD SPRING HARBOR LABORATORY PRESS

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020127511A1 (fr) 2018-12-19 2020-06-25 Firmenich Sa Compositions laitières édulcorées comprenant des produits d'hydrolyse du lactose et des glycosides de stéviol naturels glucosylés
WO2022268875A1 (fr) 2021-06-23 2022-12-29 Firmenich Sa Compositions modifiant l'arôme contenant de la lactase

Also Published As

Publication number Publication date
EP3435772A1 (fr) 2019-02-06

Similar Documents

Publication Publication Date Title
CN104334720B (zh) 具有转半乳糖基化活性的多肽
AU2014363517B2 (en) A method for preparing a dairy product having a stable content of galacto-oligosaccharide(s)
US20240180183A1 (en) Lactose reduced dairy powder
CN110868865A (zh) 具有改进的转半乳糖基活性的糖基化β-半乳糖苷酶组合物
EP3094723B1 (fr) Variantes enzymatiques améliorées de la lactase de kluyveromyces lactis
US6727084B1 (en) Cold-active beta-galactosidase, the process for its preparation and the use thereof
US20220132878A1 (en) Method for reducing lactose at high temperatures
AU2022205242A1 (en) Lactase enzymes with improved properties
CN110678479A (zh) 性能改善的乳糖酶
US9371518B2 (en) Polypeptides having transgalactosylating activity
WO2017167849A1 (fr) Composition enzymatique et préparation d&#39;un produit laitier aux propriétés améliorées
WO2017167848A1 (fr) Composition enzymatique et préparation d&#39;un produit laitier ayant des propriétés améliorées
EP3638044B1 (fr) Granulés d&#39;enzyme congelés
CN107109352A (zh) 甘露聚糖酶、纤维素酶和果胶酶缺陷型的表达β‑半乳糖苷酶和/或转半乳糖基化活性的重组宿主细胞
EP3435770A1 (fr) Production de lait à faible teneur en lactose
CN107207551A (zh) 使用具有转半乳糖基化活性的酶生产含半乳糖和果糖部分的糖类的方法
US20240341317A1 (en) Process for production of a fermented milk product using glucose-fructose oxidoreductase
RU2814542C2 (ru) Ферменты лактазы с улучшенными свойствами при кислом pH
WO2017106264A1 (fr) Procédé pour produire une lactase propre
WO2024043297A1 (fr) Procédé de production de composition, composition contenant un oligosaccharide ainsi obtenue et utilisation dudit procédé et de ladite composition
CN114514317A (zh) 使用调控改变的菌株生产乳糖酶
US20050196835A1 (en) Cold-active beta galactosidase, the process for its preparation and the use thereof

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2017714719

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2017714719

Country of ref document: EP

Effective date: 20181031

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17714719

Country of ref document: EP

Kind code of ref document: A1

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载